Alpen Group
Alpen Group SA is a Swiss EU-GMP-certified manufacturer and distributor of medical cannabis products, operating an authorized-producer platform that supplies finished products into Switzerland's FOPH cannabis pilot programs via pharmacies and retail dispensaries, with additional GDP-compliant international trading and an exclusive Swiss edible partnership with Wana Brands.
- Company typePrivate
- Founded2021
- HeadquartersQuartino, Switzerland
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Alpen Group does
Alpen Group SA is a Swiss private cannabis manufacturer and distributor operating across two sites in Ticino — an EU-GMP contract manufacturing facility in Bioggio and a cultivation campus and headquarters in Quartino. The company produces medical cannabis products to European Union Good Manufacturing Practice standards and runs GDP-compliant (Good Distribution Practice) trading and processing operations for international licensed operators. As an Authorized Producer within Switzerland's Federal Office of Public Health (FOPH) cannabis pilot programs, Alpen Group supplies finished products that are dispensed through a growing network of pharmacies and retail locations participating in regulated pilot trials.
The company monetizes through three interlocking revenue streams: EU-GMP contract manufacturing for regulated producers, finished-product supply into the Swiss Pilot Programs, and global GDP-compliant trading and processing for medical cannabis products. Its product portfolio includes EUGMP-manufactured cannabis, pilot-program SKUs, and — under an exclusive Swiss manufacturing partnership with Wana Brands (ranked the No. 1 cannabis edible brand globally) — premium cannabis edibles adapted to local regulatory requirements. Marketing and customer acquisition run through direct B2B engagement, including a website contact form and email inquiries ([email protected]); pricing is not publicly disclosed.
Alpen Group is led by a multidisciplinary team with backgrounds in pharmaceuticals, life sciences, regulated cannabis, manufacturing, and private equity. The company holds EU-GMP and GDP certifications, leverages "Swiss-made" brand equity for premium positioning, and positions itself as a platform designed for the next phase of European regulated cannabis manufacturing as the continent moves toward broader legalization frameworks.
Alpen Group firmographics
Firmographics- Name
- Alpen Group
- Legal name
- Alpen Group SA
- Website
- https://alpengroup.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Alpen Group SA is a Swiss EU-GMP-certified manufacturer and distributor of medical cannabis products, operating an authorized-producer platform that supplies finished products into Switzerland's FOPH cannabis pilot programs via pharmacies and retail dispensaries, with additional GDP-compliant international trading and an exclusive Swiss edible partnership with Wana Brands.
- Ownership category
- akta.pro rank
Alpen Group industry classification
Industry- Product category
- Pharmaceutical Cannabis Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Medical Cannabis Dispensaries (CRANAFAB)
Keywords
Where Alpen Group is headquartered
LocationHeadquarters
- HQ city
- Quartino
- HQ country
- Switzerland
- HQ region
- Europe
Offices3 records
Markets served
Alpen Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- EU-GMP Contract Manufacturing: Manufacturing medical cannabis products to EU-GMP standards for authorized producers and licensed operators in regulated markets.
- Swiss Pilot Program Supply: Supplying finished cannabis products to support research in the FOPH (Federal Office of Public Health) Pilot Programs as an authorized producer.
- GDP Trading & Processing: Providing global GDP-compliant trading and processing services for medical cannabis products across international markets.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels2 records
Alpen Group product offering
Product offeringCore offering
Alpen Group manufactures medical cannabis products to EU-GMP (European Union Good Manufacturing Practice) standards and supplies finished products as an Authorized Producer to Switzerland's FOPH Cannabis Pilot Programs. The company also provides GDP-compliant trading and processing services for medical cannabis across international markets, and serves as the exclusive Swiss manufacturing partner of Wana Brands for cannabis edible products.
Product overview
Alpen Group operates as a regulated cannabis manufacturer offering a portfolio of services and products. The core offerings include EUGMP Cannabis Contract Manufacturing services, GDP Trading & Processing for compliant international distribution, and finished products for Switzerland's FOPH Pilot Programs. Under the Wana Brands sub-brand, Alpen Group manufactures world-leading cannabis edibles (ranked No. 1 edible brand globally) as the exclusive Swiss partner, adapting proven formulations to Swiss regulatory requirements. The company positions these offerings as integrated capabilities spanning product development, manufacturing, and controlled supply within tightly governed regulatory frameworks.
Differentiator
Problem solved
Functional benefit
Brands
- Wana Brands (partnership): Alpen Group is the exclusive Swiss partner of Wana Brands, responsible for introducing and manufacturing Wana products within Switzerland's cannabis pilot programs. Wana Brands is ranked as the No. 1 edible brand globally.
Products and services
- EUGMP Cannabis Contract Manufacturing Contract manufacturing service producing medical cannabis products to EU-GMP (European Union Good Manufacturing Practice) standards for licensed cannabis operators and authorized producers in regulated European markets.
- GDP Trading and Processing Global GDP-compliant (Good Distribution Practice) trading and processing services for medical cannabis products, enabling compliant international supply chain operations across regulated markets.
- Swiss Pilot Program Products Finished cannabis products supplied to support research in the FOPH (Federal Office of Public Health) Pilot Programs, dispensed through pharmacies and retail locations participating in Switzerland's authorized cannabis pilot trials.
- Wana Brands Edibles Premium cannabis edible products manufactured under the exclusive Swiss partnership with Wana Brands — the world's leading and No. 1 ranked cannabis edible brand globally — adapted to Swiss regulatory requirements for distribution within Swiss cannabis pilot programs.
Companies that use Alpen Group
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Alpen Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Alpen Group partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Wana BrandsflagshipAlpen Group is the exclusive Swiss partner of Wana Brands, responsible for introducing and manufacturing Wana cannabis edible products within Switzerland's cannabis pilot programs. This partnership brings globally proven formulations and quality standards to the Swiss market, adapted carefully to local regulatory requirements. By partnering with Wana Brands, Alpen Group is setting a new benchmark for cannabis edibles in Switzerland.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Alpen Group competitors and assessment
Company assessmentDirect peers
- Nimbus Health: European medical cannabis distributor and manufacturer focused on pharmacy supply chains. Comparable to Alpen Group's pharmacy-led distribution model and EU-GMP supply approach.
- Sanity Group: German medical and consumer cannabis company with EU-GMP production capabilities and pharmaceutical partnerships. Directly comparable in regulated European cannabis manufacturing and B2B pharma positioning.
- Cansativa: European medical cannabis distribution platform connecting manufacturers with pharmacies. Comparable to Alpen Group's GDP-compliant trading and pharmacy-channel distribution focus.
- Demecan: Vertically integrated German medical cannabis company with EU-GMP manufacturing and cultivation. Direct comparable to Alpen Group's EU-GMP manufacturing and regulated B2B channel focus.
- Cannamedical Pharma: German-based EU-GMP certified medical cannabis producer and distributor supplying pharmacies across Europe. Direct comparable to Alpen Group's EU-GMP contract manufacturing and GDP-compliant distribution model.
Emerging players
- OrganiGram Holdings: Canadian cannabis producer with EU-GMP certification pursuing European medical cannabis distribution. Comparable as a focused manufacturer expanding into regulated European channels.
Broad incumbents
- Aurora Cannabis: Global medical cannabis producer with EU-GMP facilities supplying European markets. Comparable as a larger incumbent competing in EU-GMP contract manufacturing and distribution.
- Canopy Growth: Large global cannabis operator with European medical cannabis operations including EU-GMP production. Comparable as a multinational incumbent targeting regulated European cannabis channels.
- Jazz Pharmaceuticals (GW Pharmaceuticals): Pharmaceutical company with the only EU-approved cannabis-based medicines (Sativex, Epidiolex). Comparable as a pharmaceutical-grade cannabis player operating in tightly regulated frameworks.
- Tilray Brands: Global cannabis incumbent with EU-GMP manufacturing, broad medical cannabis portfolio, and European distribution. Comparable as a scaled EU-GMP operator competing for the same European medical cannabis contracts.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Alpen Group social profiles
Digital presenceAlpen Group compliance and trust
Trust signalCompliance2 records
Alpen Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alpen Group leadership team
Management profileNumber of profiles
Alpen Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alpen Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alpen Group
What does Alpen Group do?
Alpen Group manufactures medical cannabis products to EU-GMP (European Union Good Manufacturing Practice) standards and supplies finished products as an Authorized Producer to Switzerland's FOPH Cannabis Pilot Programs. The company also provides GDP-compliant trading and processing services for medical cannabis across international markets, and serves as the exclusive Swiss manufacturing partner of Wana Brands for cannabis edible products.
Is Alpen Group a public or private company?
Alpen Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Alpen Group founded?
Alpen Group was founded in 2021. It employs 51 to 100 people.
Where is Alpen Group based?
Alpen Group is headquartered in Quartino, Switzerland, in the Europe region.
How does Alpen Group make money?
Three revenue lines are on record. EU-GMP Contract Manufacturing is the primary driver. The others are swiss Pilot Program Supply and GDP Trading & Processing.
Who are Alpen Group's main competitors?
Direct peers on record are Nimbus Health, Sanity Group, Cansativa, Demecan and Cannamedical Pharma. OrganiGram Holdings is listed as an emerging player. Broad incumbents are Aurora Cannabis, Canopy Growth, Jazz Pharmaceuticals (GW Pharmaceuticals) and Tilray Brands.
Does Alpen Group have an API?
No public API is recorded for Alpen Group.
What industry is Alpen Group in?
Alpen Group's product category is Pharmaceutical Cannabis Manufacturing. Its primary akta.pro industry code is CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 325412 and its SIC code is 2833.